Monday, May 18, 2026
News Health

News Health

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain. Medscape Medical News Source link : https://www.medscape.com/viewarticle/enfortumab-vedotin-pembro-beats-cisplatin-resectable-mibc-2026a10006gl?src=rss...

Read more
Page 149 of 172 1 148 149 150 172

Categories

Archives

May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031